Page last updated: 2024-08-25

talinolol and ranitidine

talinolol has been researched along with ranitidine in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's12 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thakker, DR; Troutman, MD1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chreifi, G; Cinelli, MA; Li, H; Martásek, P; Poulos, TL; Roman, LJ; Silverman, RB1
Artursson, P; Mateus, A; Matsson, P1
Chreifi, G; Li, H; Martásek, P; Mukherjee, P; Poulos, TL; Roman, LJ; Sevrioukova, I; Silverman, RB1
Creemer, CN; Dai, M; Davis, DC; Kyei-Baffour, K; Mohammad, H; Seleem, MN; Younis, W1
Cinelli, MA; Kang, S; Li, H; Martásek, P; Pensa, AV; Poulos, TL; Roman, LJ; Silverman, RB1
Abd Rabo Moustafa, MM; Abdelghany, TM; Eissa, IH; Elshafeey, A; Mayhoub, AS; Mohammad, H; Qassem, OA; Seleem, MN; Younis, W1
Chreifi, G; Cinelli, MA; Li, H; Poulos, TL; Silverman, RB1
Chreifi, G; Cinelli, MA; Li, H; Martásek, P; Mukherjee, P; Pensa, AV; Poulos, TL; Roman, LJ; Silverman, RB1
Du, Y; Fu, H; Li, S; Obianyo, O; Qi, Q; Ye, K1
Chreifi, G; Do, HT; Li, H; Poulos, TL; Silverman, RB; Wang, HY1
Eslamimehr, S; Franzblau, SG; Kong, Y; Kurosu, M; Lemieux, MR; Mitachi, K; Park, F; Pressly, JD; Siricilla, S; Wang, Y; Yang, D1
Mahmoudian, M; Mirfazaelian, A1

Other Studies

16 other study(ies) available for talinolol and ranitidine

ArticleYear
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Pharmaceutical research, 2003, Volume: 20, Issue:8

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics

2003
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
    Journal of medicinal chemistry, 2014, Feb-27, Volume: 57, Issue:4

    Topics: Aminoquinolines; Catalytic Domain; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Nitric Oxide Synthase Type I

2014
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
    Journal of medicinal chemistry, 2014, Apr-10, Volume: 57, Issue:7

    Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2014
Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase.
    Journal of medicinal chemistry, 2015, Feb-12, Volume: 58, Issue:3

    Topics: Animals; Cell Membrane Permeability; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Nitric Oxide Synthase Type I; Pyrimidines; Rats; Structure-Activity Relationship

2015
Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus.
    European journal of medicinal chemistry, 2015, Aug-28, Volume: 101

    Topics: Animals; Anti-Bacterial Agents; Caco-2 Cells; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin Resistance

2015
Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21

    Topics: Aminoquinolines; Caco-2 Cells; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Models, Molecular; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenyl Ethers; Structure-Activity Relationship

2015
Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    European journal of medicinal chemistry, 2017, Apr-21, Volume: 130

    Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Carbanilides; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance

2017
Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.
    Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9

    Topics: Aminoquinolines; Animals; Drug Discovery; Enzyme Inhibitors; Humans; Nitric Oxide Synthase Type I; Nitriles; Rats

2017
Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: Aminoquinolines; Animals; Caco-2 Cells; Cattle; Cell Membrane Permeability; Enzyme Assays; Histidine; Humans; Mice; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats

2017
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Female; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Structure-Activity Relationship; Xanthine

2017
Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.
    Journal of medicinal chemistry, 2017, 11-22, Volume: 60, Issue:22

    Topics: Aminopyridines; Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeability; Crystallography, X-Ray; Fluorobenzenes; Humans; Mice; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Structure-Activity Relationship; Swine; Theophylline; Verapamil

2017
An antimycobacterial pleuromutilin analogue effective against dormant bacilli.
    Bioorganic & medicinal chemistry, 2018, 09-15, Volume: 26, Issue:17

    Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Caco-2 Cells; Diterpenes; Female; Half-Life; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pleuromutilins; Polycyclic Compounds

2018
A simple pharmacokinetics subroutine for modeling double peak phenomenon.
    Biopharmaceutics & drug disposition, 2006, Volume: 27, Issue:3

    Topics: Algorithms; Computer Simulation; Models, Biological; Pharmacokinetics; Phenazopyridine; Piroxicam; Propanolamines; Ranitidine; Software

2006